Team Internet (formally CentralNic) has had its target price adjusted to 180p by Berenberg, which notes that implies 45% upside from the current share price.
A trading update this morning said the outlook for the current year is “at least” in line with expectations: The current consensus range is US$783m-834m (the mid-point is $808.5m) for gross revenue and $91m-98m for adjusted EBITDA (the mid-point is $94.5m).
Cavendish analyst James McCormack has reiterated a bullish price target for 88 Energy pLtd of 1.1p against a 0.35p publication price.
It follows 88 Energy’s first foray into Namibia in a notable expansion of the oil and gas exploration and production company’s footprint.
Novo Nordisk (NYSE:NVO) did not disappoint with the latest trial data update of its blockbuster diabetes drug Wegovy, according to analysts at US bank Citi.
Full results from the SELECT trial released on Saturday confirmed that patients had shed weight but also that it cut the risk of a non-fatal heart attack by 28% and non-fatal strokes by 7% in patients considered overweight.
British Land Company PLC (LSE:BLND)'s shares pushed higher after what Stifel called "a resilient set of results given the market backdrop."
The broker pointed out the portfolio valuation is down just 2.5%, taking the net tangible asset to 565p, which now appears to be approaching the "nadir."
Spirits group Diago PLC might have more bad news to come for investors, according to two top City brokers.
Shares in the Johnnie Walker, Guinness and Smirnoff group tanked 15% on Friday as it warned of slowing growth in Latin America/Caribbean, a region that accounts for around 11% of sales.
Birkenstock’s flotation on the New York Stock Exchange this October may have underwhelmed, but it’s Dr Martens PLC (LSE:DOCS) in London that is really feeling the wear and tear.
Shares of the iconic German-founded British boot brand hit a new all-time low on Monday, taking the FTSE 250 constituent 75% below its 2021 flotation price.